Lausanne, Switzerland – Saphetor SA, a Swiss precision medicine company and creator of the VarSome suite of bioinformatics solutions, today announced the appointment of Esteban Czwan as Chief Commercial Officer, effective 5th December 2025. Esteban will be responsible for global commercial strategy and activity as Saphetor continues its expansion into key markets. “We are all […]
Toronto — BenchSci, a leading provider of AI software for biopharma research and development, today announced a renewed two-year contract with Merck, known as MSD outside of the United States and Canada. “Seeing Merck’s teams use ASCEND to unravel disease biology, strengthen hypotheses, and make more evidence-driven decisions underscores the real scientific value AI can […]
Team to develop and validate computational models trained on data from organoids and advanced human model systems that will improve drug safety and reduce reliance on animal testing NEW YORK — Inductive Bio, an AI drug discovery partner developing virtual chemistry labs, announced today that it has received an up to $21M award to lead a […]
We’re proud to highlight that Tyrolpath, the largest private pathology lab in western Austria, is the first lab in Austria to adopt MSK-IMPACT®-Flex powered with SOPHiA DDM™, marking a major milestone for precision oncology in the country. With approximately 45,000 new cancer diagnoses reported each year, there is a strong need for comprehensive genomic profiling (CGP) to identify […]
DNASTAR is pleased to announce a new distribution partnership with ONEOMICS PRIVATE LIMITED, now serving as the authorized representative for Lasergene® bioinformatics software in South India. Through this collaboration, researchers across the region will gain expanded access to the full range of DNASTAR tools for genomics, molecular biology, and structural biology, supported by dedicated local […]
Proprietary agentic AI model transforms genomic and real-world data into actionable insights across the full drug lifecycle Enables faster development of breakthrough therapies, including tumor-agnostic cancer treatments, through a 360-degree view of the precision medicine landscape Empowers scientific researchers across the life sciences and healthcare continuum to perform large-scale data analysis for the advancement of […]
BOSTON and SAN DIEGO — SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pace and accessibility of scientific discovery, today announced at the Association for Molecular Pathology (AMP) Annual Meeting a partnership that unites sequencing and AI analytics to streamline genomic workflows and accelerate the research supporting […]
BOSTON — Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, to launch and co-market MSK-ACCESS® and MSK-IMPACT® powered with SOPHiA DDM™ on Complete Genomics’ DNBSEQ-T1+ sequencing platform. The companies aim to broaden access to precision oncology testing by offering the best-in-class liquid biopsy […]
mzio GmbH and Bright Giant GmbH announce a new integration between mzmine and SIRIUS. This collaboration enables researchers to launch SIRIUS analysis directly from mzmine feature tables, automating result handling and eliminating the need for manual data transfer to streamline small molecule discovery workflows. Bremen, Germany and Jena, Germany – mzio GmbH, the company behind the […]
Redefining Scalability, Automation, and Clinical Yield in Genomic Interpretation BOZEMAN, Mont. — Golden Helix, Inc. announced the release of VarSeq 3 and VSWarehouse 3, the company’s next-generation platform for secondary and tertiary genomic analysis. Building on more than a decade of trusted innovation, the clinical utility of VarSeq 3 has been expanded through industry partnerships and customer collaborations. […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
